Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Is Spinraza worth $750K? Biogen says yes, spelling out reduced death risk
Is Spinraza worth $750K? Biogen says yes, spelling out reduced death risk
Is Spinraza worth $750K? Biogen says yes, spelling out reduced death risk
Submitted by
admin
on January 13, 2017 - 9:41am
Source:
Endpoints
News Tags:
Biogen
Spinraza
SMA
spinal muscular atrophy
Headline:
Is Spinraza worth $750K? Biogen says yes, spelling out reduced death risk
Do Not Allow Advertisers to Use My Personal information
